Venture Investors was part of a $30 million Series D financing round for Delphinus, the company announced today.
The Detroit-based Delphinus, a medical imaging company, developed SoftVue, the first circular array transducer technology to help with dense breast screenings.
According to a release, the funds will be used to help with the worldwide commercialization of SoftVue.
Other participants in the financing round include Arboretum Ventures and Beringea.
One thought on “Venture Investors Invests in Delphinus”